ICON Public Limited Company
HealthcareNASDAQ:ICLR · NASDAQ Global Select
-$4.14 today
Vol 0.70M · Avg 1.16M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $647.3M |
| Receivables | $2.7B |
| Other Current | $105.3M |
| Total Current Assets | $3.5B |
| PP&E (Net) | $524.7M |
| Goodwill | $8.7B |
| Intangible Assets | $3.2B |
| Long-term Investments | $82.0M |
| Tax Assets | $106.9M |
| Other Non-current | $75.7M |
| Total Non-current Assets | $12.8B |
| Total Assets | $16.3B |
Analysis
Selected assets total $16.3B for Latest. The largest visible component is Goodwill at $8.7B, about 53.7% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $647.3M +20.1% | $538.8M +42.5% | $378.1M +30.9% | $288.8M -61.6% | $752.2M | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $0 | $0 -100.0% | $2.0M +14.1% | $1.7M +0.1% | $1.7M | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $2.7B -3.6% | $2.9B -1.7% | $2.9B +3.5% | $2.8B +35.1% | $2.1B | $533.8M | $399.4M | -$1.7B |
| Inventory | $0 | $0 | $0 -100.0% | $7.1M | $0 | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $105.3M -25.0% | $140.4M +6.3% | $132.1M +1.6% | $130.0M | $0 | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $3.5B -0.8% | $3.5B +3.5% | $3.4B +5.6% | $3.2B +9.8% | $2.9B | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $524.7M -1.1% | $530.5M +5.8% | $501.5M -0.5% | $504.2M -5.7% | $534.6M | $1.2B | $1.5B | $687.8M |
| Goodwill | $8.7B -3.5% | $9.1B +0.3% | $9.0B +0.6% | $9.0B -0.7% | $9.0B | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $3.2B -8.8% | $3.6B -7.7% | $3.9B -9.9% | $4.3B -9.2% | $4.7B | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $82.0M +41.6% | $57.9M +23.8% | $46.8M +43.4% | $32.6M +30.7% | $25.0M | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $106.9M +43.0% | $74.8M +1.5% | $73.7M -4.2% | $76.9M +59.0% | $48.4M | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $75.7M +4.0% | $72.8M -7.2% | $78.5M -14.9% | $92.2M +3.3% | $89.2M | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $12.8B -4.3% | $13.3B -1.7% | $13.6B -2.7% | $14.0B -3.4% | $14.4B | -$15.3B | $14.8B | $11.3B |
| Total Assets | $16.3B -3.6% | $16.9B -0.7% | $17.0B -1.1% | $17.2B -1.2% | $17.4B | $13.3B | $11.9B | $10.6B |
| Account Payables | $780.9M +10.8% | $704.6M +18.3% | $595.5M -2.6% | $611.4M +169.4% | $227.0M | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $529.8M +1680.0% | $29.8M -73.0% | $110.2M +99.7% | $55.1M +0.0% | $55.1M | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $19.0M -65.6% | $55.3M +295.6% | $14.0M -66.6% | $41.8M -29.7% | $59.4M | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $1.6B -4.0% | $1.6B -2.4% | $1.7B +9.8% | $1.5B +13.9% | $1.3B | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $279.7M -21.2% | $355.2M -14.4% | $415.1M +1572.1% | $24.8M -94.4% | $439.8M | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $3.2B +14.3% | $2.8B -1.0% | $2.8B +5.0% | $2.7B +8.5% | $2.5B | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $2.9B -15.4% | $3.4B -7.3% | $3.7B -20.3% | $4.6B -14.5% | $5.4B | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $714.4M -12.1% | $812.5M -9.6% | $899.1M -9.1% | $988.6M -9.0% | $1.1B | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 -100.0% | $735.0K | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $176.1M -15.9% | $209.3M -10.0% | $232.7M -16.1% | $277.4M +29.7% | $214.0M | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $3.9B -14.9% | $4.6B -7.4% | $4.9B -17.9% | $6.0B -12.3% | $6.8B | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $7.1B -3.8% | $7.4B -5.1% | $7.7B -10.8% | $8.7B -6.8% | $9.3B | $14.7B | $3.7B | $9.6B |
| Common Stock | $6.3M -4.3% | $6.6M -1.7% | $6.7M +0.8% | $6.6M +0.1% | $6.6M | $651.4M | $517.0M | $382.6M |
| Retained Earnings | $2.1B -22.1% | $2.7B +12.0% | $2.4B +33.6% | $1.8B +28.6% | $1.4B | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | -$68.5M +70.0% | -$228.6M -60.6% | -$142.3M +17.0% | -$171.5M -88.6% | -$90.9M | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $1.6M | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $1.4B | $337.8M | $931.4M |
| Total Equity | $9.2B -3.5% | $9.5B +3.1% | $9.2B +8.7% | $8.5B +5.3% | $8.1B | $9.1B | $7.7B | $3.3B |
| Total Debt | $3.6B -1.3% | $3.6B -8.5% | $3.9B -18.5% | $4.8B -14.5% | $5.6B | $724.2M | $410.6M | $399.4M |
| Net Debt | $2.9B -5.1% | $3.1B -13.9% | $3.6B -21.6% | $4.5B -7.2% | $4.9B | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Exact Sciences Corporation
EXAS
$20.03B
Guardant Health, Inc.
NASDAQ:GH
$17.31B
Neurocrine Biosciences, Inc.
NASDAQ:NBIX
$16.15B
Solventum Corporation
NYSE:SOLV
$13.54B
Medpace Holdings, Inc.
NASDAQ:MEDP
$13.40B
The Cooper Companies, Inc.
NASDAQ:COO
$13.22B
Revvity, Inc.
NYSE:RVTY
$11.11B
Encompass Health Corporation
NYSE:EHC
$10.11B
Universal Health Services, Inc.
NYSE:UHS
$9.18B
Qiagen N.V.
NYSE:QGEN
$7.65B
SEC Filings
Recent regulatory filings
No filings found.
How much cash does ICLR have?
ICON Public Limited Company (ICLR) reported $647.29M in cash and equivalents in fiscal 2025.
How much debt does ICLR carry?
ICON Public Limited Company (ICLR) reported $3.56B of total debt, with net debt of $2.91B.
Explore More
Continue the stock analysis
Jump to another research area for this company.